請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/20386
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 伍安怡(Betty A. Wu-Hsieh) | |
dc.contributor.author | Min-Jhen Jheng | en |
dc.contributor.author | 鄭敏貞 | zh_TW |
dc.date.accessioned | 2021-06-08T02:47:02Z | - |
dc.date.copyright | 2017-09-08 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-08-21 | |
dc.identifier.citation | Ala, A., Dhillon, A.P., and Hodgson, H.J. (2003). Role of cell adhesion molecules in leukocyte recruitment in the liver and gut. International journal of experimental pathology 84, 1-16.
Arevalo, M.T., Simpson-Haidaris, P.J., Kou, Z., Schlesinger, J.J., and Jin, X. (2009). Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection. J Med Virol 81, 519-528. Basu, A., Jain, P., Sarkar, P., Gangodkar, S., Deshpande, D., Ganti, K., Shetty, S., and Ghosh, K. (2011). Dengue virus infection of SK Hep1 cells: inhibition of in vitro angiogenesis and altered cytomorphology by expressed viral envelope glycoprotein. FEMS immunology and medical microbiology 62, 140-147. Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., Drake, J.M., Brownstein, J.S., Hoen, A.G., Sankoh, O., et al. (2013). The global distribution and burden of dengue. Nature 496, 504-507. Blum, M.S., Toninelli, E., Anderson, J.M., Balda, M.S., Zhou, J., O'Donnell, L., Pardi, R., and Bender, J.R. (1997). Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. The American journal of physiology 273, H286-294. Bosch, I., Xhaja, K., Estevez, L., Raines, G., Melichar, H., Warke, R.V., Fournier, M.V., Ennis, F.A., and Rothman, A.L. (2002). Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 76, 5588-5597. Brecher, M., Zhang, J., and Li, H. (2013). The flavivirus protease as a target for drug discovery. Virol Sin 28, 326-336. Brown, M.G., Hermann, L.L., Issekutz, A.C., Marshall, J.S., Rowter, D., Al-Afif, A., and Anderson, R. (2011). Dengue virus infection of mast cells triggers endothelial cell activation. J Virol 85, 1145-1150. Capaldo, C.T., and Nusrat, A. (2009). Cytokine regulation of tight junctions. Biochim Biophys Acta 1788, 864-871. Cardier, J.E., Rivas, B., Romano, E., Rothman, A.L., Perez-Perez, C., Ochoa, M., Caceres, A.M., Cardier, M., Guevara, N., and Giovannetti, R. (2006). Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium : journal of endothelial cell research 13, 335-340. Chambers, T.J., Hahn, C.S., Galler, R., and Rice, C.M. (1990). Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44, 649-688. Chayama, K., Takahashi, S., Toyota, J., Karino, Y., Ikeda, K., Ishikawa, H., Watanabe, H., McPhee, F., Hughes, E., and Kumada, H. (2012). Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders. Hepatology (Baltimore, Md) 55, 742-748. Chen, H.C., Hofman, F.M., Kung, J.T., Lin, Y.D., and Wu-Hsieh, B.A. (2007). Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81, 5518-5526. Chen, H.R., Chuang, Y.C., Lin, Y.S., Liu, H.S., Liu, C.C., Perng, G.C., and Yeh, T.M. (2016). Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy. PLoS neglected tropical diseases 10, e0004828. Chen, S.T., Lin, Y.L., Huang, M.T., Wu, M.F., Cheng, S.C., Lei, H.Y., Lee, C.K., Chiou, T.W., Wong, C.H., and Hsieh, S.L. (2008). CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453, 672-676. Chen, Y.C., and Wang, S.Y. (2002). Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 76, 9877-9887. Cruz-Oliveira, C., Freire, J.M., Conceicao, T.M., Higa, L.M., Castanho, M.A., and Da Poian, A.T. (2015). Receptors and routes of dengue virus entry into the host cells. FEMS microbiology reviews 39, 155-170. Dalrymple, N., and Mackow, E.R. (2011). Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol 85, 9478-9485. Dalrymple, N.A., and Mackow, E.R. (2012). Roles for endothelial cells in dengue virus infection. Adv Virol 2012, 840654. Dejana, E. (2004). Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5, 261-270. Etzioni, A. (1996). Adhesion molecules--their role in health and disease. Pediatric research 39, 191-198. Gentile, I., Buonomo, A.R., Zappulo, E., Minei, G., Morisco, F., Borrelli, F., Coppola, N., and Borgia, G. (2014). Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. Ther Clin Risk Manag 10, 493-504. Gurney, K.J., Estrada, E.Y., and Rosenberg, G.A. (2006). Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 23, 87-96. Guzman, M.G., and Harris, E. (2015). Dengue. The Lancet 385, 453-465. Halstead, S.B. (1989). Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Reviews of infectious diseases 11 Suppl 4, S830-839. Johnson, A.J., and Roehrig, J.T. (1999). New mouse model for dengue virus vaccine testing. J Virol 73, 783-786. King, A.D., Nisalak, A., Kalayanrooj, S., Myint, K.S., Pattanapanyasat, K., Nimmannitya, S., and Innis, B.L. (1999). B cells are the principal circulating mononuclear cells infected by dengue virus. The Southeast Asian journal of tropical medicine and public health 30, 718-728. Lampugnani, M.G., and Dejana, E. (1997). Interendothelial junctions: structure, signalling and functional roles. Current opinion in cell biology 9, 674-682. Lawson, C., and Wolf, S. (2009). ICAM-1 signaling in endothelial cells. Pharmacological reports : PR 61, 22-32. Lee, Y.R., Liu, M.T., Lei, H.Y., Liu, C.C., Wu, J.M., Tung, Y.C., Lin, Y.S., Yeh, T.M., Chen, S.H., and Liu, H.S. (2006). MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 87, 3623-3630. Leung, D., Schroder, K., White, H., Fang, N.X., Stoermer, M.J., Abbenante, G., Martin, J.L., Young, P.R., and Fairlie, D.P. (2001). Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem 276, 45762-45771. Lin, J.C., Lin, S.C., Chen, W.Y., Yen, Y.T., Lai, C.W., Tao, M.H., Lin, Y.L., Miaw, S.C., and Wu-Hsieh, B.A. (2014). Dengue viral protease interaction with NF-kappaB inhibitor alpha/beta results in endothelial cell apoptosis and hemorrhage development. Journal of immunology (Baltimore, Md : 1950) 193, 1258-1267. Lin, K., Perni, R.B., Kwong, A.D., and Lin, C. (2006). VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells. Antimicrobial agents and chemotherapy 50, 1813-1822. Lindenbach, B.D., and C. M. Rice. (2003). Molecular biology of flavivirus. AdvVirus Res 59, 23-61. Lindenbach, B.D., and Rice, C.M. (2003). Molecular biology of flaviviruses. Advances in virus research 59, 23-61. Luplertlop, N., and Misse, D. (2008). MMP cellular responses to dengue virus infection-induced vascular leakage. Japanese journal of infectious diseases 61, 298-301. Matter, K., and Balda, M.S. (2003). Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4, 225-236. Menendez-Arias, L. (2013). Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments. Antiviral research 98, 93-120. Mustafa, M.S., Rasotgi, V., Jain, S., and Gupta, V. (2015). Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India 71, 67-70. Nordlund, K. (2015). Combating dengue with infectious disease forecasting Centers for Disease Control and Prevention Orozco, S., Schmid, M.A., Parameswaran, P., Lachica, R., Henn, M.R., Beatty, R., and Harris, E. (2012). Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol 93, 2152-2157. Oshima, T., Laroux, F.S., Coe, L.L., Morise, Z., Kawachi, S., Bauer, P., Grisham, M.B., Specian, R.D., Carter, P., Jennings, S., et al. (2001). Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvascular research 61, 130-143. Pang, T., Cardosa, M.J., and Guzman, M.G. (2007). Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunology and cell biology 85, 43-45. Peyrefitte, C.N., Pastorino, B., Grau, G.E., Lou, J., Tolou, H., and Couissinier-Paris, P. (2006). Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes. J Med Virol 78, 229-242. Pinheiro, F.P., and Corber, S.J. (1997). Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World health statistics quarterly Rapport trimestriel de statistiques sanitaires mondiales 50, 161-169. Prandini, M.H., Dreher, I., Bouillot, S., Benkerri, S., Moll, T., and Huber, P. (2005). The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene 24, 2992-3001. Sarrazin, C., Rouzier, R., Wagner, F., Forestier, N., Larrey, D., Gupta, S.K., Hussain, M., Shah, A., Cutler, D., Zhang, J., et al. (2007). SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders. Gastroenterology 132, 1270-1278. Screaton, G., Mongkolsapaya, J., Yacoub, S., and Roberts, C. (2015). New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol 15, 745-759. Shresta, S., Sharar, K.L., Prigozhin, D.M., Snider, H.M., Beatty, P.R., and Harris, E. (2005). Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. Journal of immunology (Baltimore, Md : 1950) 175, 3946-3954. Suksanpaisan, L., Cabrera-Hernandez, A., and Smith, D.R. (2007). Infection of human primary hepatocytes with dengue virus serotype 2. J Med Virol 79, 300-307. Sumarmo, Wulur, H., Jahja, E., Gubler, D.J., Suharyono, W., and Sorensen, K. (1983). Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull World Health Organ 61, 693-701. Talavera, D., Castillo, A.M., Dominguez, M.C., Gutierrez, A.E., and Meza, I. (2004). IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85, 1801-1813. Tornavaca, O., Chia, M., Dufton, N., Almagro, L.O., Conway, D.E., Randi, A.M., Schwartz, M.A., Matter, K., and Balda, M.S. (2015). ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol 208, 821-838. Tsai, W.L., Cheng, J.S., Shu, C.W., Lai, K.H., Chan, H.H., Wu, C.C., Wu, J.M., Hsu, P.I., Chung, R.T., and Chang, T.H. (2017). Asunaprevir Evokes Hepatocytes Innate Immunity to Restrict the Replication of Hepatitis C and Dengue Virus. Front Microbiol 8, 668. Wallez, Y., and Huber, P. (2008). Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778, 794-809. Wang, S., He, R., Patarapotikul, J., Innis, B.L., and Anderson, R. (1995). Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213, 254-257. Wheelock, M.J., and Johnson, K.R. (2003). Cadherin-mediated cellular signaling. Current opinion in cell biology 15, 509-514. Wu, S.J., Grouard-Vogel, G., Sun, W., Mascola, J.R., Brachtel, E., Putvatana, R., Louder, M.K., Filgueira, L., Marovich, M.A., Wong, H.K., et al. (2000). Human skin Langerhans cells are targets of dengue virus infection. Nature medicine 6, 816-820. Yen, Y.T., Chen, H.C., Lin, Y.D., Shieh, C.C., and Wu-Hsieh, B.A. (2008). Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol 82, 12312-12324. Yu, C.Y., Chang, T.H., Liang, J.J., Chiang, R.L., Lee, Y.L., Liao, C.L., and Lin, Y.L. (2012). Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS pathogens 8, e1002780. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/20386 | - |
dc.description.abstract | 登革病毒是世界上重要的蟲媒傳染性疾病之一。具有登革出血熱(DHF)或登革休克症候群(DSS)的患者相對於登革熱(DF)患者有較高的死亡率。藉由登革出血小鼠模式動物,浸潤到皮下組織的巨噬細胞會產生TNF且內皮細胞會有細胞凋亡的現象。在這個研究中,將以出血小鼠的皮膚及登革感染後的內皮細胞探討關於內皮細胞的黏著分子(adhesion molecules)、趨化因子(chemokines)及緊密連接蛋白(tight junction proteins)等特徵在登革病毒刺激後所產生的變化。在登革病毒感染後第五天會在Stat1剔除鼠的皮膚觀察到出血現象。透過抗體陣列分析,M-CSF、CCL2、CCL3、CCL5及CXCL2的表現量在病毒感染後都會顯著提升。藉由免疫螢光染色的方式,在病毒感染後第三天在出血皮膚上便可以看到大量的巨噬細胞浸潤的情況,且可以觀察到內皮細胞在病毒感染後第五天會表現高量的ICAM-1。從皮膚亦可以觀察到緊密連接蛋白ZO-1及occludin皆會受到病毒影響而有所改變。在體外實驗系統的研究中,登革病毒會造成內皮細胞HUVEC或HMEC-1及硫乙醇酸(thioglycollate)在Stat1剔除鼠所引發的巨噬細胞產生巨噬細胞的趨化因子,且受登革感染的巨噬細胞上亦會表現趨化因子受體CCR2。雖然以重組蛋白TNF或登革病毒直接刺激HMEC-1只能造成ICAM-1的低度表現,但兩者的組合下便能顯著提升ICAM-1的表現量。再者,登革病毒會促使HMEC-1 的occludin表現量下降且ZO-1被切割後的片段會釋出到胞外,由此可推斷登革病毒可能是透過破壞內皮細胞間的緊密連接蛋白而改變其通透性。接著我們探討了C型肝炎病毒蛋白酶抑制劑(asunaprevir)是否會對登革感染及出血產生影響。Stat1剔除鼠在感染登革病毒後以管餵的方式連續投藥,asunaprevir會減少脾臟中的病毒含量及促發炎細胞因子Tnf的表現量,且在腹部皮膚上的出血情況也有減緩的趨勢。
這個研究顯示登革病毒感染會造持內皮細胞產生功能性改變,包含黏著分子、趨化因子的增加及緊密連接蛋白的改變。這些在內皮細胞上產生的變化對於出血發生可能扮演著舉足輕重的腳色。另外在小鼠身上進行asunaprevir的藥效探討則提供了針對登革病毒感染上老藥新用的發展契機。 | zh_TW |
dc.description.abstract | Dengue virus (DENV) is one of the most important vector-borne infectious diseases in the world. Patients with dengue hemorrhagic fever or dengue shock syndrome (DHF/DSS) have much higher mortality than those with dengue fever (DF). We established a hemorrhage mouse model in Stat1-/- mice by inoculating 106 PFU of DENV intradermally. Stat1-/- mice developed hemorrhage on day 5 after infection. By using antibody array, we discovered that M-CSF, CCL2, CCL3, CCL5 and CXCL2 were up-regulated in the skin on day 5 after infection when hemorrhage developed. Immunofluorescence staining of skin cryosections revealed that ICAM-1 was upregulated on CD31+ endothelial cells and macrophage infiltration was detected as early as day 3 after infection. Western blotting analysis of homogenized skin tissues showed that tight junction proteins ZO-1 and occludin were altered when hemorrhage developed.
In vitro studies showed that DENV infection induces HUVEC, HMEC-1 and thioglycollate-elicited Stat1-/- macrophages to produce macrophage chemoattractants and that macrophages expressed chemokine receptor CCR2. While rhTNF and DENV separately induced marginal expressions of ICAM-1 in HMEC-1, DENV combined with TNF treatment significantly enhanced ICAM-1 expression. Moreover, DENV infection increased the release of cleaved ZO-1 in HMEC-1. These results suggest that DENV infection causes tight junction disruption thereby changing the permeability of endothelial cells. To test the effect of asunaprevir, DENV-infected Stat1-/- mice were given asunaprevir intragastrically at the time of and after infection. Results showed that asunaprevir reduced viral load and Tnf transcripts in the spleen as well as the severity of hemorrhage development in the abdominal skin compared to vehicle controls. These data showed that repurposing asunaprevir for treatment of dengue is potentially a feasible approach. This study revealed that DENV infection resulted in functional changes of endothelial cells which may be crucial to hemorrhage development. Moreover, we showed that Stat1-/- mice are useful in testing the efficacy of potential anti-DENV drugs. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T02:47:02Z (GMT). No. of bitstreams: 1 ntu-106-R04449003-1.pdf: 4033259 bytes, checksum: bc5241662180c41ef9941b54df6c3f62 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 致謝………………...…………………………………………...…………………...…..i
中文摘要…………………………………………………...…...……...………...……ii Abstract…………………………………………………………...…………...……..iii Table of contents…………………………………………………...…………...…..v List of figures……………………………………...…………....……………...…..vii Chapter I. Introduction………...…………....…………...…………....…………..1 1. Dengue virus and diseases………………………………………………...….….1 2. Target cells of DENV………….…………………………………………..….….2 3. Dengue hemorrhage mouse model…………………………………………....….3 4. Chemokines and cytokines in relation to endothelial permeability………..…….4 5. Expression of adhesion molecules on activated endothelial cells…….……...….5 6. Junctional proteins of vascular endothelial cells ………………………….…….6 7. Asunaprevir as a HCV protease inhibitor…………………………………..…....7 Chapter II. Specific aims……………………………………………………....….9 Chapter III. Material and methods……...…………....……………...………..12 Part I. Materials……………………………………………………...……...………….12 Part II. Methods………………………………………………………………......…….25 Chapter IV. Results………...…………....…………...…………....……………...31 1. The kinetic change of hemorrhage development as well as cytokine and chemokine expression in Stat1-/- mice………………………………………………………......31 2. CD31+ endothelial cell expressed ICAM-1 correlates with macrophage infiltration into hemorrhage skin …………………………………………...…………………..33 3. ZO-1 and occludin expressions are upregulated in skin of hemorrhage mouse……..33 4. Endothelial cells produce CCL2 and CCL5 after DENV infection…………...……34 5. Macrophages produce macrophage chemoattractants and chemokine receptor after DENV infection…………………..………………………………………………...34 6. Combined treatment of TNF and DENV enhances ICAM-1 expression on endothelial cells………………………………………………….…………………35 7. ZO-1 and occludin expression and distribution on DENV-infected HMEC-1………36 8. Asunaprevir treatment reduces DENV-induced hemorrhage in Stat1-/- mice……………………………………….…………………….………………….36 Chapter V. Conclusion and discussion………………………………………..39 Chapter VI. References……………………………………………….………….43 Chapter VII. Figures……………………………………………………..……….49 | |
dc.language.iso | zh-TW | |
dc.title | 探討登革病毒在Stat1剔除鼠皮膚血管內皮細胞功能之影響 | zh_TW |
dc.title | The kinetic change in the expression of functional proteins in skin endothelial cells of dengue hemorrhage in Stat1-/- mice | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 繆希椿(Shi-Chuen Miaw),顧家綺(Chia-Chi Ku) | |
dc.subject.keyword | 登革病毒,登革出血,黏著分子,緊密連接蛋白,巨噬細胞浸潤, | zh_TW |
dc.subject.keyword | Dengue virus,Dengue hemorrhage,adhesion molecules,tight junction proteins,macrophage infiltration,asunaprevir, | en |
dc.relation.page | 85 | |
dc.identifier.doi | 10.6342/NTU201703915 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2017-08-21 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 免疫學研究所 | zh_TW |
顯示於系所單位: | 免疫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 3.94 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。